{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:38:13Z","timestamp":1789879093699,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.coi.2006.05.004","type":"journal-article","created":{"date-parts":[[2006,6,13]],"date-time":"2006-06-13T11:22:33Z","timestamp":1150197753000},"page":"449-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Vaccine development against malaria"],"prefix":"10.1016","volume":"18","author":[{"given":"Kai","family":"Matuschewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2006.05.004_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/216160a0","article-title":"Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei","volume":"216","author":"Nussenzweig","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.coi.2006.05.004_bib2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/339409","article-title":"Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites","volume":"185","author":"Hoffman","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2006.05.004_bib3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/414751a","article-title":"Imperfect vaccines and the evolution of pathogen virulence","volume":"414","author":"Gandon","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.coi.2006.05.004_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0952-7915(93)90037-S","article-title":"Transmission-blocking immunity against malaria and other vector-borne diseases","volume":"5","author":"Kaslow","year":"1993","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2006.05.004_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1365-3024.2002.00450.x","article-title":"Effects of irradiation on Plasmodium falciparum sporozoite hepatic development: implications for the design of pre-erythrocytic malaria vaccines","volume":"24","author":"Silvie","year":"2002","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.coi.2006.05.004_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.0105-2896.2004.00175.x","article-title":"Effector and memory CD8+ T cells as seen in immunity to malaria","volume":"201","author":"Morrot","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2006.05.004_bib7_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature03188","article-title":"Genetically modified Plasmodium parasites as a protective experimental malaria vaccine","volume":"433","author":"Mueller","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.coi.2006.05.004_bib8","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1073\/pnas.0408442102","article-title":"Plasmodium liver stage developmental arrest by depletion of a protein at the parasite\u2013host interface","volume":"102","author":"Mueller","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2006.05.004_bib9","doi-asserted-by":"crossref","first-page":"12194","DOI":"10.1073\/pnas.0500925102","article-title":"Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of liver cells","volume":"102","author":"van Dijk","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2006.05.004_bib10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1645\/GE-3348RN","article-title":"Additional observations on the sporozoite transmission of Plasmodium knowlesi to monkeys","volume":"90","author":"Collins","year":"2004","journal-title":"J Parasitol"},{"key":"10.1016\/j.coi.2006.05.004_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1126\/science.1067159","article-title":"Complete development of mosquito phases of the malaria parasite in vitro","volume":"295","author":"Al-Olayan","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.coi.2006.05.004_bib12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(02)09784-2","article-title":"Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum","volume":"360","author":"Pombo","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2006.05.004_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite Plasmodium falciparum","volume":"419","author":"Gardner","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.coi.2006.05.004_bib14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1126\/science.6204384","article-title":"DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope","volume":"225","author":"Enea","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.coi.2006.05.004_bib15","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.4049\/jimmunol.175.11.7575","article-title":"Human CD4+ T cells induced by synthetic peptide malaria vaccine are comparable to cells elicited by attenuated Plasmodium falciparum sporozoites","volume":"175","author":"Calvo-Calle","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2006.05.004_bib16","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.4049\/jimmunol.171.12.6961","article-title":"Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN\u03b3","volume":"171","author":"Sun","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2006.05.004_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nm1009","article-title":"A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease","volume":"10","author":"Reece","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2006.05.004_bib18","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/318534","article-title":"Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria","volume":"183","author":"Kester","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2006.05.004_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jmv.20524","article-title":"Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines","volume":"78","author":"Zuckerman","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.coi.2006.05.004_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199701093360202","article-title":"A preliminary evaluation of a recombinant circumsporozoite vaccine against Plasmodium falciparum malaria. RTS,S malaria vaccine evaluation group","volume":"336","author":"Stoute","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2006.05.004_bib21","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS,S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial","volume":"364","author":"Alonso","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2006.05.004_bib22","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(05)67669-6","article-title":"Duration of protection with RTS,S\/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial","volume":"366","author":"Alonso","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2006.05.004_bib23","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(05)17860-X","article-title":"Malaria vaccine: 3 or 6 month's protection","volume":"365","author":"Smith","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2006.05.004_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.pt.2005.08.002","article-title":"The Plasmodium sporozoite survives RTS,S vaccination","volume":"21","author":"Snounou","year":"2005","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.coi.2006.05.004_bib25","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1371\/journal.pmed.0010033","article-title":"A randomized, double-blind, controlled vaccine efficacy trial of DNA\/MVA ME-TRAP against malaria infection in Gambian adults","volume":"1","author":"Moorthy","year":"2004","journal-title":"PloS Med"},{"key":"10.1016\/j.coi.2006.05.004_bib26_1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20041526","article-title":"Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model","volume":"201","author":"Tao","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2006.05.004_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1473-3099(01)00016-0","article-title":"Yellow fever: an update","volume":"1","author":"Monath","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2006.05.004_bib28","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1006\/jmbi.2001.5258","article-title":"Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus","volume":"315","author":"Bonaldo","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.coi.2006.05.004_bib29","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"Barba-Spaeth","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2006.05.004_bib30","doi-asserted-by":"crossref","unstructured":"Sundaresh S, Doolan DL, Hirst S, Mu Y, Unal B, Davies H, Felgner PL, Baldi P: Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques. Bioinformatics 2006. in press.","DOI":"10.1093\/bioinformatics\/btl162"},{"key":"10.1016\/j.coi.2006.05.004_bib31","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.coi.2006.05.004_bib32_1","first-page":"49","article-title":"An epidemiological approach to malaria vaccine discovery: hypothesis and preliminary results","volume":"5","author":"Titanji","year":"2005","journal-title":"J Cameroon Acad Sci"},{"key":"10.1016\/j.coi.2006.05.004_bib33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1073\/pnas.0408782102","article-title":"Profiling the humoral immune response to infection by using proteome microarrays: high throughput vaccine and diagnostic antigen discovery","volume":"102","author":"Davies","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2006.05.004_bib34_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/eji.200425807","article-title":"Immune responses to Plasmodium vivax pre-erythrocytic stage antigens in naturally exposed duffy-negative humans: a potential model for identification of liver-stage antigens","volume":"35","author":"Wang","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coi.2006.05.004_bib35","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/192733a0","article-title":"Gamma-globulin and acquired immunity to human malaria","volume":"192","author":"Cohen","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.coi.2006.05.004_bib36","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1038\/6560","article-title":"Immunity to non-cerebral severe malaria is acquired after one or two infections","volume":"5","author":"Gupta","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2006.05.004_bib37","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1073\/pnas.84.9.3014","article-title":"Merozoite surface coat precursor protein completely protects aotus monkeys against Plasmodium falciparum malaria","volume":"84","author":"Siddiqui","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2006.05.004_bib38","doi-asserted-by":"crossref","unstructured":"Stoute JA, Gombe J, Withers MR, Siangla J, McKinney D, Onyango M, Cummings JF, Milman J, Tucker K, Soisson L et al.: Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya. Vaccine 2006. in press.","DOI":"10.1016\/j.vaccine.2005.11.037"},{"key":"10.1016\/j.coi.2006.05.004_bib39","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1128\/IAI.74.2.1313-1322.2006","article-title":"Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum","volume":"74","author":"Woehlbier","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2006.05.004_bib40_1","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1371\/journal.pmed.0020344","article-title":"A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum","volume":"2","author":"Druilhe","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.coi.2006.05.004_bib41","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1086\/429671","article-title":"B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area","volume":"191","author":"Dorfman","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2006.05.004_bib42","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.4049\/jimmunol.175.4.2510","article-title":"Plasmodium yoelii can ablate vaccine-induced long-term protection in mice","volume":"175","author":"Wykes","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2006.05.004_bib43","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.168.4.1307","article-title":"Cytoadherence by Plasmodium falciparum-infected erythrocytes is correlated with the expression of a family of variable proteins on infected erythrocytes","volume":"168","author":"Magowan","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2006.05.004_bib44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nm0398-358","article-title":"Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria","volume":"4","author":"Bull","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2006.05.004_bib45","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/500150","article-title":"Immunization of aotus monkeys with recombinant cysteine-rich interdomain region 1\u03b1 protects against severe disease during Plasmodium falciparum reinfection","volume":"193","author":"Makobongo","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2006.05.004_bib46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4269\/ajtmh.2001.64.28","article-title":"The burden of malaria in pregnancy in malaria-endemic areas","volume":"64","author":"Steketee","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coi.2006.05.004_bib47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4269\/ajtmh.2004.71.41","article-title":"The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa","volume":"71","author":"ter Kuile","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coi.2006.05.004_bib48","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/27570","article-title":"Maternal antibodies block malaria","volume":"395","author":"Fried","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.coi.2006.05.004_bib49","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1126\/science.272.5267.1502","article-title":"Adherence of Plasmodium falciparum to chondrotin sulfate A in the human placenta","volume":"272","author":"Fried","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.coi.2006.05.004_bib50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2958.2003.03570.x","article-title":"Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria","volume":"49","author":"Salanti","year":"2003","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.coi.2006.05.004_bib51","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.20041579","article-title":"Evidence for the involvement of VAR2CSA in pregnancy-associated malaria","volume":"200","author":"Salanti","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2006.05.004_bib52_1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.embor.7400466","article-title":"A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A","volume":"6","author":"Viebig","year":"2005","journal-title":"EMBO Rep"},{"key":"10.1016\/j.coi.2006.05.004_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2006.05.004_bib54","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJM199807233390402","article-title":"A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent lyme disease","volume":"339","author":"Sigal","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2006.05.004_bib55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.177.2.505","article-title":"Pgs28 belongs to a family of epidermal growth factor-like antigens that are a target of malaria transmission-blocking antibodies","volume":"177","author":"Duffy","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2006.05.004_bib56","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.vaccine.2004.12.019","article-title":"Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria","volume":"23","author":"Malkin","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2006.05.004_bib57","doi-asserted-by":"crossref","first-page":"26635","DOI":"10.1074\/jbc.M401385200","article-title":"Plasmodium ookinete-secreted proteins secreted through a common micronemal pathway are targets of blocking malaria transmission","volume":"279","author":"Li","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2006.05.004_bib58_1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1126\/science.1103717","article-title":"A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analysis","volume":"307","author":"Hall","year":"2005","journal-title":"Science"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791506001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791506001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:19:44Z","timestamp":1760602784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791506001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0952791506001014"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2006.05.004","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine development against malaria","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2006.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}